ACXP.OQ - Acurx Pharmaceuticals Inc
Maxim GroupEstimate Decrease, Price Target Revision
Raising PT to $10 on Expansion of Ibeza into Recurrent C Diff Infection Study; Could Reduce Timelines, Broaden Scope of Use
公司
ACXP.OQ
日期
2026-03-13
分析师
Jason McCarthy, Ph.D.
页数
7 页
需要登录
请登录后购买研报或生成音频内容。